Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Curcumin Solid Dispersion Pellets in Inflammatory Bowel Disease
IRCT20250406065227N1Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in inflammatory bowel disease (IBD), Crohn's disease and autoimmune colitis, sponsored by Mashhad University of Medical Sciences. Started Sep 2025; status: recruiting.
02
Drugs
curcumin
03
Conditions
inflammatory bowel disease (IBD)Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on IRCT20250406065227N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250406065227N1.